X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

Data as of Oct 17
 -0.06 / -3.51%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

XTL Biopharmaceuticals Ltd. is engaged in the acquisition, development, and commercialization of proprietary and pharmaceutical products. It also develops therapeutics such as erythropoietin program, SAM-101, and diversity oriented synthesis program. These medical products are created for the treatment of multiple myeloma, schizophrenia, and hepatitis C. The company was founded on March 9, 1993 and is headquartered in Herzliya, Israel.

Contact Information

XTL Biopharmaceuticals Ltd.
Herzliya Business Park
Herzliya -- 46766
P:(729) 955-7080
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Joshua LevineChief Executive Officer
David KestenbaumChief Financial Officer
Moshe MittelmanMedical Director
Daniel SpiraInternal Auditor
Navon ShalomController

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.